Putnam Investments’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.77M | Sell |
|
|||||
|
2021
Q1 | $2.35M | Sell |
|
|||||
|
2020
Q4 | $10.8M | Buy |
|
|||||
|
2020
Q3 | $6.83M | Sell |
|
|||||
|
2020
Q2 | $6.72M | Buy |
|
|||||
|
2020
Q1 | $5.27M | Buy |
|
|||||
|
2019
Q4 | $225K | Hold |
|
|||||
|
2019
Q3 | $203K | Hold |
|
|||||
|
2019
Q2 | $272K | Hold |
|
|||||
|
2019
Q1 | $281K | Sell |
|
|||||
|
2018
Q4 | $205K | Sell |
|
|||||
|
2018
Q3 | $153M | Sell |
|
|||||
|
2018
Q2 | $144M | Buy |
|
|||||
|
2018
Q1 | $81.7M | Buy |
|
|||||
|
2017
Q4 | $397K | Sell |
|
|||||
|
2017
Q3 | $564K | Sell |
|
|||||
|
2017
Q2 | $533K | Sell |
|
|||||
|
2017
Q1 | $115M | Buy |
|
|||||
|
2016
Q4 | $586K | Sell |
|
|||||
|
2016
Q3 | $588K | Buy |
|
|||||
|
2016
Q2 | $549K | Hold |
|
|||||
|
2016
Q1 | $654K | Hold |
|
|||||
|
2015
Q4 | $897K | Hold |
|
|||||
|
2015
Q3 | $735K | Sell |
|
|||||
|
2015
Q2 | $922K | Buy |
|
|||||
|
2015
Q1 | $832K | Buy |
|
|||||
|
2014
Q4 | $833K | Sell |
|
|||||
|
2014
Q3 | $1.29M | Hold |
|
|||||
|
2014
Q2 | $1.22M | Hold |
|
|||||
|
2014
Q1 | $1.19M | Hold |
|
|||||
|
2013
Q4 | $1.04M | Buy |
|
|||||
|
2013
Q3 | $850K | Buy |
|
|||||
|
2013
Q2 | $673K | Buy |
|